Format:
16
ISSN:
2159-8290
Content:
The clinical relevance of comprehensive molecular analysis in rare cancers is not established. We analyzed the molecular profiles and clinical outcomes of 1,310 patients (rare cancers, 75.5%) enrolled in a prospective observational study by the German Cancer Consortium that applies whole-genome/exome and RNA sequencing to inform the care of adults with incurable cancers.
Note:
Gesehen am 16.06.2021
In:
Cancer discovery, Philadelphia, Pa. : [Verlag nicht ermittelbar], 2011, 11(2021), 11, Seite 2780-2795, 2159-8290
In:
volume:11
In:
year:2021
In:
number:11
In:
pages:2780-2795
In:
extent:16
Language:
English
DOI:
10.1158/2159-8290.CD-21-0126
URL:
Volltext
(lizenzpflichtig)
URL:
Volltext
(lizenzpflichtig)
Bookmarklink